{"id":"ciclonicate","rwe":[{"pmid":"4017475","year":"1985","title":"[Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].","finding":"","journal":"La Clinica terapeutica","studyType":"Clinical Study"},{"pmid":"6673630","year":"1983","title":"[Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II].","finding":"","journal":"Annali italiani di chirurgia","studyType":"Clinical Study"},{"pmid":"7155375","year":"1982","title":"[Treatment of arteriosclerotic peripheral vascular diseases with ciclonicate].","finding":"","journal":"Minerva cardioangiologica","studyType":"Clinical Study"}],"tags":[{"label":"ciclonicate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"C04AC07","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"cyclonicate","offLabel":[],"synonyms":["ciclonicate","cyclonicate"],"timeline":[],"approvals":[],"brandName":"Cyclonicate","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"ciclonicate","explanation":"Think of it like a key fitting into a lock. Cyclonicate is thought to be a key that fits into a specific lock in the body, allowing it to influence the way certain cells or processes work. However, the exact shape of the key and the lock, as well as how they interact, are still not fully understood.","oneSentence":"Cyclonicate is believed to work by interacting with specific biological pathways, although the exact mechanism is unknown.","technicalDetail":"Cyclonicate is a small molecule that binds to a specific target, although the identity of this target is currently unknown. This binding event triggers a cascade of downstream effects, leading to the drug's therapeutic or adverse effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3908","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CICLONICATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:36:55.658299","biosimilars":[],"competitors":[{"drugName":"nicotinic acid","drugSlug":"nicotinic-acid","fdaApproval":"1957-07-24","relationship":"same-class"},{"drugName":"inositol nicotinate","drugSlug":"inositol-nicotinate","fdaApproval":"","relationship":"same-class"}],"genericName":"ciclonicate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"nicotinic-acid","brandName":"nicotinic acid","genericName":"nicotinic acid","approvalYear":"1957","relationship":"same-class"},{"drugId":"inositol-nicotinate","brandName":"inositol nicotinate","genericName":"inositol nicotinate","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"7H634NXI03","CHEBI":"CHEBI:135007","INN_ID":"3808","UMLSCUI":"C0055710","ChEMBL_ID":"CHEMBL2104521","KEGG_DRUG":"D07173","DRUGBANK_ID":"DB13709","PUBCHEM_CID":"10444661","MESH_SUPPLEMENTAL_RECORD_UI":"C032821"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"C04AC07","allCodes":["C04AC07"]},"biosimilarFilings":[],"recentPublications":[{"date":"1985 Mar 31","pmid":"4017475","title":"[Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].","journal":"La Clinica terapeutica"},{"date":"1983","pmid":"6673630","title":"[Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II].","journal":"Annali italiani di chirurgia"},{"date":"1982 Nov","pmid":"7155375","title":"[Treatment of arteriosclerotic peripheral vascular diseases with ciclonicate].","journal":"Minerva cardioangiologica"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cyclonicate, also known as CICLONICATE, is a small molecule drug in the ciclonicate class. Its exact target and mechanism of action are unknown, but it is believed to work by interacting with specific biological pathways. The commercial status of Cyclonicate is unclear, and it is not known whether it is patented or available as a generic medication. Further research is needed to determine its approved indications, half-life, bioavailability, and key safety considerations. As a result, Cyclonicate is not yet widely used in clinical practice.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}